| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 5.210 | 5.374 | 5.023 | 8.108 | 26.637 | 56.907 | 58.050 |
| Total Income - EUR | - | - | - | 5.210 | 5.448 | 7.045 | 8.108 | 26.723 | 56.915 | 58.060 |
| Total Expenses - EUR | - | - | - | 2.062 | 907 | 5.317 | 22.088 | 11.553 | 30.552 | 31.805 |
| Gross Profit/Loss - EUR | - | - | - | 3.148 | 4.541 | 1.728 | -13.980 | 15.170 | 26.363 | 26.255 |
| Net Profit/Loss - EUR | - | - | - | 2.992 | 4.378 | 1.587 | -14.223 | 14.492 | 25.805 | 24.723 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Hemimmun Consult S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 1.512 | 909 | 327 | 1.732 | 1.221 | 4.766 |
| Current Assets | - | - | - | 3.035 | 5.898 | 9.171 | 7.226 | 3.264 | 28.827 | 29.189 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 568 | 1.354 | 4.646 | 1.092 | 1.495 | 22.066 | 9.375 |
| Cash | - | - | - | 2.467 | 4.543 | 4.525 | 6.135 | 1.768 | 6.761 | 19.814 |
| Shareholders Funds | - | - | - | 3.035 | 7.354 | 8.801 | -5.617 | 1.152 | 25.862 | 31.422 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 0 | 56 | 6.561 | 13.170 | 3.844 | 4.187 | 2.533 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Hemimmun Consult S.r.l.